COV vs EBR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

45LOW

EBR

EBR SYSTEM CDI FORUS [EBR]

45LOW

Score Breakdown

COV EBR
Technical
44
47
Catalyst
53
55
Sentiment
50
50
Fundamental
60
42
Momentum
64
23
Risk Gate
46
42

Key Metrics

COV Metric EBR
$63.8MMarket Cap$175.7M
122KAvg Volume (20d)2.8M
N/AShort Interest+0.1%
$0.90052-Week High$1.475
$0.33552-Week Low$0.365
-6.2%Daily Change-2.6%
$0.455Entry Price$0.380
-49.6%ROE-458.8%
-157.4%Profit MarginN/A

Active Signals

COV Signals

●RSI drifting toward oversold territory — worth watching
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.2% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●Strong revenue growth (+373%)
●Small-cap ($20-100M)

EBR Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 3.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (2.0 quarters)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

Ask Scout AI to compare COV and EBR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
COV Full Analysis → EBR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).